Echo IQ Growth Projections (3-5 Years)Market...

Echo IQ Growth Projections (3-5 Years)

Market Opportunity:

• 12,000,000 echocardiograms in the USA, Europe, and the Middle East.

• Targeting a 10% market share (1,200,000 echocardiograms per year).

Revenue Potential:

• Estimated revenue per hospital (Aortic Stenosis & Heart Failure): AUD 650 per dual test.

• Total revenue from the target market: AUD 780,000,000.

• Echo IQ’s estimated share (30% of total revenue): AUD 234,000,000.

Profitability Estimates:

• Gross profit (estimated at 2/3 of Echo IQ’s revenue share): AUD 156,000,000.

• Net profit (70% of gross profit): AUD 109,200,000.

• Estimated net profit per share: AUD 0.1603.

Valuation Projections:

• Applying a P/E ratio of 25.

• Estimated market cap: AUD 2.73 billion.

• Estimated share price: AUD 4.01.

Assumptions:

• The addressable market is likely larger, though this is a conservative estimate.

• The logic holds if the underlying assumptions remain valid.

• Conducting a sensitivity analysis on market adoption, pricing, and margins would provide further insight.

• Adjustments to margins and the P/E ratio could impact the estimated share price range.

• Outstanding Shares (Including Performance): 681,221,000.

Conclusion:

• In my opinion, Echo IQ presents a significant growth opportunity in the echocardiogram AI market, offering strong revenue potential and profit margins. This projection highlights the potential for substantial growth.

• This is not investment advice, these are my personal Echo IQ growth projections. Please DYOR and invest according to your financial means and risk tolerance.